Chemoprophylaxis, diagnosis, treatments, and discharge management of COVID-19: An evidence-based clinical practice guideline (updated version)
Abstract The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of a rapidly spreading illness, coronavirus disease 2019 (COVID-19), affecting more than seventeen million people around the world. Diagnosis and treatment guidelines for clinicians caring for patients are n...
Similar Items
-
Construction and Optimization of an Urban Ecological Security Pattern Based on Habitat Quality Assessment and the Minimum Cumulative Resistance Model in Shenzhen City, China
by: Yu-Zhe Zhang, et al.
Published: (2021-06-01) -
Neuropeptide Y Gene Promoter -399T/C Polymorphism Increases Risk of Ischemic Stroke
by: Xue-Feng Fu, et al.
Published: (2013-06-01) -
Preparation of Maleic Anhydride Grafted Polybutene and Its Application in Isotactic Polybutene-1/Microcrystalline Cellulose Composites
by: Bo Wang, et al.
Published: (2018-04-01) -
Anti-inflammatory Mechanism of Geniposide: Inhibiting the Hyperpermeability of Fibroblast-Like Synoviocytes via the RhoA/p38MAPK/NF-κB/F-Actin Signal Pathway
by: Ran Deng, et al.
Published: (2018-02-01) -
Detection of B. anthracis spores and vegetative cells with the same monoclonal antibodies.
by: Dian-Bing Wang, et al.
Published: (2009-11-01)